US FDA Experts Advise Industry On How To Rid Drug Manufacturing Processes Of Nitrosamines
No Uniform Checklist for Performing Risk Assessments
• By Joanne S. Eglovitch
FDA Says Manufacturers Need To Understand Nitrosamine Risks In Order To Control Them • Source: Shutterstock 
